|
⚲
|
| Solas BioVentures Management LLC
✚
|
|
|---|---|
| CRD # | 322344 |
| SEC # | 801-134738 |
| CIK # | |
| AUM | $165.0 M (2026-04-16) |
| Employees | 6 (83% Investors, 0% Brokers) |
| Phone | 423-243-3460 |
| Address | 412 Georgia Avenue Chattanooga, TN 37403 |
| Source | [IAPD] [Website] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| VC | Solas Areteia SPV | 2025-10-10 | 1.8 | |
| VC | Solas Arrivo B Sidecar | 2025-10-10 | 1.8 | |
| VC | Solas Basking Holdings | [2025-10-10] | 9.0 | 9.0 |
| VC | Solas BioVentures Emerging Healthcare Fund LP | [2025-10-10] | 35.1 | 48.6 |
| VC | Solas BioVentures Fund II LP | [2025-10-10] | 35.1 | 28.7 |
| VC | Solas BioVentures Fund I LP | 2025-10-10 | 10.6 | |
| VC | Solas Cryosa Sidecar | [2025-10-10] | 6.9 | 3.5 |
| VC | Solas Francis Sidecar | [2025-10-10] | 9.0 | 31.0 |
| VC | Solas Intershunt Sidecar | [2025-10-10] | 1.4 | 1.5 |
| VC | Solas Maclellan Group JV | 2025-10-10 | 12.3 | |
| VC | Solas Stimdia Sidecar | [2025-10-10] | 7.5 | 5.3 |
| VC | Solas Tvardi Sidecar | [2025-10-10] | 13.3 | 0.6 |
| VC | Solas Vesalio Sidecar | [2025-10-10] | 5.6 | 12.0 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 165.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 12 | 165.0 |
| By Discretionary | ||
| Discretionary | 12 | 165.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 12 | 165.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 165.0 | |
| Total | 12 | 165.0 |
| Form D Directors | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|
| David Adair | 29 | ||
| Michael Hoey | 19 | ||
| David Belitz | 14 | ||
| Mark Hackett | 14 | ||
| Charles Adair | 3 | ||
| Solas BioVentures Management LLC | 9 | ||
| Solas Partners II LLC | 7 | ||
| Solas BioVentures Emerging Healthcare GP LLC | 2 |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Path Capital Partners LLC
✚
|
FL | 0.2 |
|
Overlay Management LLC
✚
|
GA | 0.2 |
|
Frontline Healthcare Partners LLC
✚
|
SC | 0.2 |
|
Norland Capital LP
✚
|
0.2 | |
|
Wingman Growth Partners LP
✚
|
CT | 0.2 |
|
Evolution Private Investment Collective LLC
✚
|
CA | 0.2 |
|
V29 Capital Management LLC
✚
|
0.2 | |
|
Conifer Infrastructure Management Company LLC
✚
|
PA | 0.2 |
|
Marquee Capital Advisors LLC
✚
|
IL | 0.2 |
|
Maple Park Capital Partners Management LP
✚
|
TX | 0.2 |